Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07385157
Eligibility Criteria:
Patients:
* Adults over 18 years old
* Clinical diagnosis of epilepsy, considered pharmacoresistant
* Clinical diagnosis of mild to moderate ID based on the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) and the International Statistical Classfication of Diseases and Related Health Problems (11th ed; ICD-11; World Health Organisation, 2022).Patient has the capacity to consent to take part in the study, and does so
* Able to tolerate the dummy device (device worn for at least 40% of a 1-2 week test period)
Family member / carer:
* Family member/carer is willing to keep a routine seizure diary for the course of the study
* Retrospective seizure diary data available for the proceeding last 6 months
* According to family member, carer, or clinical record, the participant is having at least monthly 'episodes of interest' (it may be unclear whether these are epileptic or behavioural episodes)
* Agree to participate to the study, and support study activities and comply to these
Healthcare professional:
* PwID recommended by their epileptologist for long-term EEG monitoring
* Agree to participate to the study, and support study activities and comply to these
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07385157
Study Brief:
Protocol Section:
NCT07385157